Analysis of the promoter of the MUC1 gene overexpressed in breast cancer  by Zaretsky, Joseph Z. et al.
Analysis of the promoter of the MUC1 gene overexpressed in
breast cancer
Joseph Z. Zaretskya;*, Ronit Saridb, Yael Aylona, Leonid A. Mittelmanc,
Daniel H. Wreschnera, Iafa Keydara
aDepartment of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv 69978, Israel
bDepartment of Human Microbiology, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel
cInterdepartmental Core Facility, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel
Received 3 October 1999
Abstract The MUC1 gene encodes a mucin glycoprotein and is
overexpressed in breast cancer. Knowledge of the mechanisms
leading to MUC1 overexpression may help in the development of
molecular approaches for breast cancer therapy. In order to
study the regulation of the MUC1 gene transcription, we
analyzed functional activities of various deletion mutants of the
MUC1 promoter. We established that transcriptional cis-
elements present in the SacI/XmnI fragment of the promoter
are competent and sufficient for expression of, at least, tandem
repeats containing isoform(s) of the MUC1 protein. CAT
transfection analysis showed that both the 3P and 5P regions of
the SacI/XmnI fragment possess transcription activities. Pro-
moter activities associated with the SacI/XmnI fragment were
confirmed by a RNase protection assay, which demonstrated
multiple transcription start sites (TSSs) in the MUC1 gene
transcribed in epithelial T47D cells. We show that treatment of
the T47D cells with TGFL1 leads to activation of additional
TSSs in the MUC1 gene. The roles of the structural and
functional properties of the MUC1 promoter in MUC1 gene
transcription are discussed.
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1. Introduction
MUC1 is a glycoprotein which is expressed at a basal level
in most epithelial cells [1]. In breast cancer cells, its expression
is dramatically increased [1^3]. To date, several isoforms of
the MUC1 gene product have been identi¢ed and character-
ized [4^8]. The MUC1/REP isoform contains a 20 amino acid
tandem repeat array and participates in cell to cell interactions
[4,9]. The MUC1/Y protein, which lacks the tandem repeats,
exhibits features common to cytokine receptors and may be
involved in signal transduction [5,8,10]. The secreted MUC1/
SEC isoform may act as a ligand for the MUC1/Y membrane
receptor protein [8]. Recently, it has been shown that the
MUC1/SEC protein may also inhibit proliferation of T-cells
[11].
It appears that expression of the various MUC1 protein
isoforms, especially those involved in signal transduction,
must be highly regulated. It was shown that expression of
the MUC1 gene is controlled at the transcriptional level
[2,12^14]. Nonetheless, knowledge about regulation of its ex-
pression is limited. Although several transcription cis-elements
have been identi¢ed in the MUC1 promoter [12^14], these
data are not su⁄cient to build a detailed map of the cis-ele-
ments present in the promoter. On the other hand, such a map
would allow one to evaluate the potentials of the MUC1 gene
to be transcribed in di¡erent types of cells. Still undetermined
is whether transcription of the MUC1 gene is associated with
synthesis of a single primary transcript or whether several
primary transcripts are generated at various transcriptional
start sites. It is known that the 0.8 kb SacI/XmnI fragment,
located at the 3P end of the MUC1 promoter, is a minimal
fragment that can direct transcription of the test genes at
maximal levels [14]. However, it has not been studied whether
this region is also competent to direct expression of the
MUC1 protein.
We addressed these questions in the present study. We per-
formed a computer analysis of the MUC1 promoter DNA
sequence for potential transcription cis-elements and con-
structed the map of transcriptional cis-elements found in the
SacI/XmnI region of the MUC1 promoter. We analyzed func-
tional activities of various MUC1 promoter fragments and
showed that the SacI/XmnI fragment controls the expression
of at least tandem repeat containing isoforms of the MUC1
protein. We also showed that both the 3P and 5P end regions
of the SacI/XmnI fragment possess independent promoter ac-
tivities in transfection assays. Finally, we examined the tran-
scription start site(s) (TSS) of the MUC1 gene and found that
in mammary carcinoma T47D cells, transcription of this gene
is associated with multiple TSSs and that additional TSSs may
be activated by treatment of the cells with TGFL1.
2. Materials and methods
2.1. Cell cultures
Human breast adenocarcinoma T47D cells, human breast epithelial
HBL-100 cells and canine fetal thymus Cf2Th cells were propagated
as described [15^17].
2.2. Plasmids
The MUC1 promoter containing vector was constructed by replac-
ing of the HMG promoter in the pHMG/Cl642/MUC1 expression
vector [18], which includes a 4.3 kb MUC1 cDNA sequence, by the
SacI/XmnI fragment of the 5P end sequence of the MUC1 gene (Figs.
2 and 3A). A promoter-less pCl642/MUC1 plasmid was constructed
by excision of the HMG promoter from the pHMG/C1642/MUC1
expression vector.
The CAT test gene containing constructs were prepared as follows.
The linker oligonucleotide including HindIII, BstXI, XmaI, SacI,
XmnI, Bsu36I and XbaI restriction sites was inserted into the cloning
region of the promoter-less pCAT/enh plasmid (Promega), enabling
incorporation of the SacI/XmnI MUC1 promoter fragment. Digestion
of the resulting plasmid, pPr/CAT/enh, with BstXI, XmaI or Bsu36I
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restriction enzymes produced deletion mutants used in CAT trans-
fection assays.
2.3. Transient transfection assay
Cells were transfected utilizing the Ca-phosphate precipitation
method or liposomal technique [19]. After 24^48 h, MUC1 protein
expression was ascertained by immunohistochemical staining with
H23 monoclonal antibody (mAb) [20] that recognizes an epitope with-
in the MUC1 tandem repeat array. CAT activity in lysates of the
transfected cells was detected as described [19].
2.4. RNase protection assay (RPA)
RPAs were performed using Ambion HSH kit according to the
manufacturer’s recommendations [21]. Total RNA was extracted
from the cells [22]. The RNA probe for RPA was synthesized by
SP6 RNA polymerase from a SacI/XmnI MUC1 fragment cloned
into pGEM-7Zf plasmid and was size-puri¢ed in a 6% polyacrylamide
gel (Fig. 4, IIC).
2.5. Computer analysis
The computer analysis of the potential transcription cis-elements in
the MUC1 promoter was performed by using the TRANSFAC and
TSSG databases on transcription factors and their DNA binding sites
[23,24]. The MUC1 promoter sequence was obtained from the Gen-
Bank NCBI (accession no. X69118). The degree of sequence homol-
ogy considered signi¢cant and used in this study for most of the cis-
elements is 0.8^1.0.
3. Results
3.1. Competence of the SacI/XmnI fragment for MUC1 gene
transcription
Previous studies showed that the SacI/XmnI region of the
MUC1 promoter could drive maximal transcription of test
genes [13,14,25]. In order to study the competence of the
SacI/XmnI fragment in controlling expression of MUC1 pro-
tein isoform(s), we inserted the SacI/XmnI fragment upstream
to the human MUC1 coding sequence, cloned in an expres-
sion vector, and analyzed the promoter activity by transient
transfection of murine DA3 cells. Transfected cells were
screened using the mAb H23 speci¢c for tandem repeat con-
taining isoforms of the MUC1 protein.
Fig. 1A shows that murine cells transfected with pPr/
CL642/MUC1 plasmid containing the SacI/XmnI sequence
were able to express the human MUC1 protein. The same
expression vector but devoid of the SacI/XmnI fragment,
pPr/CL642/MUC1, was insu⁄cient for MUC1 protein synthe-
sis in transfected cells (negative control, data not shown). For
a positive control, pHMG/CL642/MUC1 was used in which
the SacI/XmnI fragment was substituted with the housekeep-
ing HMG promoter. The resulting plasmid expressed MUC1
protein at high levels (Fig. 1B).
Thus, the SacI/XmnI fragment of the MUC1 promoter con-
tains a set of cis-elements necessary for expression of the
MUC1 protein (at least its tandem repeat containing iso-
forms) in mouse mammary epithelial cells.
3.2. A computer analysis of potential cis-elements in MUC1
promoter
As the SacI/XmnI fragment can drive transcription of the
MUC1 tandem repeat containing isoform(s), we wanted to
know which transcriptional cis-elements may participate in
this control. For this purpose, we have performed a computer
search for potential transcription cis-elements present in the
SacI/XmnI fragment.
Transcription results from interplay between transcription
responsible proteins (transcription factors and RNA polymer-
ase) with transcription speci¢c DNA sequences (cis-elements).
These two principle components, proteins and DNA sequen-
ces, are equal and necessary partners in the transcription proc-
ess and absence of either one will abolish transcription. A
computer analysis of promoter DNA sequences is an appro-
priate method for identifying transcription cis-elements. What
transcription factors will interact with the cis-elements present
in a given promoter depends on the cell type, transcription
factor composition, their concentration and a⁄nity for the
speci¢c cis-elements. The computer analysis cannot answer
these questions. However, if the degree of homology between
the promoter sequences and the cis-element consensus sequen-
ces is su⁄ciently high, it may demonstrate the promoter cis-
element content, draw the structural complexity of a promoter
and reveal the potentials of a given gene to be transcribed in
di¡erent types of cells. This is the main value of computer cis-
elements analysis.
Fig. 1. Human MUC1 protein expression in transiently transfected
mouse DA3 cells. A: Immunostaining of the MUC1 protein in cells
transfected with plasmid pPr/CL642/MUC1. B: Immunostaining of
the MUC1 protein in cells transfected with pHMG/CL642/MUC1
plasmid (positive control). For negative control, pCL642/MUC1
plasmid lacking promoter sequence was used (data not shown). For
immunostaining, monoclonal H23 mAb speci¢c for tandem repeats
of the MUC1 protein was used.
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Presence of limited numbers of transcription cis-elements in
the MUC1 promoter has already been reported [13,14,25].
Our search revealed a much more complex picture of the
cis-element setting. We have discovered 104 di¡erent elements
in the sense strand and 67 elements in the antisense strand and
built a detailed map of the cis-elements present in the MUC1
promoter (Fig. 2). Our analysis showed that among these
elements, there are (1) ubiquitous transcription cis-elements
such as TATA-box, CCAAT-, E- and GC-boxes and elements
that bind AP1, AP2, AP3, AP4, CTF/NF1, ER, PR, Sp1,
STAT1, STAT3, STAT5 and YY1 ubiquitous transcription
factors, (2) the elements that regulate transcription in mam-
mary epithelial cells (MAF, MGF, MP4, RME, PMR, SpA
and WAP), (3) the elements that are speci¢c for transcription
in hematopoetic cells (BKLF/TEFII, GATA1, v-Myb, c-Myb
and MZF1), (4) the elements that drive transcription in im-
munospeci¢c cells (AML-1, G¢-1, Ikaros, IL-6 RE, LyF1,
NF-GMCSF, NF-mu-E1, NF-Y, Pu-box, SRY, TCF-1, TdT
Inr, XBP1 and W-element), (5) the elements that are speci¢c
for transcription in hepatocytes (ARP-1, HNF-5, LF-A1 and
H-APF1), (6) the elements that control transcription in muscle
cells (Myo D, Nkx-2.5 and SEF1) and (7) the elements speci¢c
for viral promoters (JCV, LBP-1, LVC, PEA1 and PEA3, PV-
E2, T-Ag SV40, retroviral TATA-box, TEF-1, TEF-2 and
TFII-ML-Inr2) (Fig. 2) [26^30].
As one can see in Fig. 2, the MUC1 promoter is charac-
terized by a high density of transcriptional cis-elements dis-
tributed along the promoter DNA. Extensive overlapping se-
quences speci¢c for di¡erent cis-elements create clusters of cis-
elements. Some clusters are composed primarily of cis-ele-
ments speci¢c for a de¢nite transcription factor (for example,
the cluster located at 360/345 is speci¢c for Sp1 factor).
Other clusters contain overlapping sequences speci¢c for sev-
eral functionally unrelated factors (for example, the cluster
located at 3516/3474 nucleotides is composed of binding
sites speci¢c for Ikaros proteins, STAT, ELK-1, c-REL,
MZF-1, IL-6, MGF, Nkx-2.5, NF-kB, c-Myb and RME).
One may speculate that speci¢c combination of di¡erent cis-
elements in a cluster and the position of a cluster along the
promoter DNA sequences may determine the mode of tran-
scription of a particular gene in a de¢nite type of cells. In
di¡erent cells, di¡erent clusters of the same promoter may
be in contact with or be in close proximity to the initiation
transcription complex, thus specifying the pattern of tran-
scription.
Among di¡erent cis-element combinations found in the
MUC1 promoter, the combinations of the overlapping cis-
elements which may interact with the transcriptional activa-
tors or repressors are of particular interest. For example, the
combinations of YY1 repressor binding sites with cis-elements
speci¢c for initiator TFII-ML-Inr-2 (3669/3651) or for var-
ious trans-activators such as MGF (3424/3412), Sp1 (3424/
3396), MAF (3424/3392), HNF-5 (3314/3302), PEA1
(3159/3140), PV-E2 (3159/3137) and c-Myb (3159/3131)
are abundant in the MUC1 promoter. Another example is
the NF-kB activator speci¢c sequence (3373/3364) which
overlaps the sequence speci¢c for NEF1 repressor (3366/
3355). At last, at the very 3P end of the MUC1 promoter,
there is a binding site for the NEF1 repressor (34/+7) which
overlaps one of the main basal TSSs (Figs. 2 and 4). This
combination of the overlapping sequences creates a possibility
for inhibition of the MUC1 gene transcription in cells where
NEF1 repressor successfully competes for the indicated site
with the transcription initiation factors.
In conclusion, the computer analysis of the potential cis-
elements revealed a high level of structural complexity of the
MUC1 promoter that might be re£ected in functional com-
plexity as well. To test this possibility, we performed a func-
tional analysis of di¡erent parts of the MUC1 promoter.
3.3. Functional analysis of the MUC1 promoter: transcription
activities associated with the 5P and 3P end regions of the
SacI/XmnI fragment
For a more detailed analysis of the SacI/XmnI promoter
region, the CAT transfection assays were performed. The
SacI/XmnI fragment or its deleted forms were inserted into
pCAT/enh vector and the resulting constructs were analyzed
by CAT assays in three di¡erent cell lines: human breast
carcinoma T47D cells, human mammary epithelial HBL-100
cells and canine fetal thymus Cf2Th cells.
The BstXI/XmnI (3593/+31) fragment obtained by deletion
of the SacI/BstXI sequence from the full-length SacI/XmnI
fragment maintained 74.3 and 77.4% of the maximal activity
of the SacI/XmnI fragment in epithelial HBL-100 and T47D
cells, respectively (Fig. 3B, line 2). Cf2Th thymus cells, trans-
fected with the BstXI/XmnI fragment, supported only 29.2%
of the full-length fragment CAT activity. We assume that
some elements deleted from the BstXI/XmnI fragment are
more crucial for expression in thymus cells than in mammary
epithelial cells. To test this assumption, a synthetic 25 base
oligonucleotide corresponding to a part of the cluster XIII
located at the 3618/3593 position (Fig. 2) was added to the
5P end of the BstXI/XmnI fragment and the new construct was
analyzed by CAT assay. CAT activity was increased 2.2-fold
relative to the BstXI/XmnI fragment in thymus Cf2TH cells,
whereas in epithelial cells, only a small increase in CAT ac-
tivity was detected (Fig. 3B, line 3). These results showed that
the added 25 bp sequence indeed contains cis-elements that
are more essential for transcription from the MUC1 promoter
in thymus cells than in epithelial cells. The computer analysis
indicates that among the cis-elements present within this 25 bp
sequence, there are four elements (K-IRE, Ikaros 1, Ikaros 2
and Pu-box) (Fig. 2) that are speci¢c for gene expression in
immune cells [23,24,29,30].
Further analysis of the MUC1 promoter deletion mutants
showed that CAT activity of the construct, containing the
XmaI/XmnI fragment (3410/+31), decreased to 20% in
Cf2Th cells and to 37.8 and 32.8% in T47D and HBL-100
cells, respectively (Fig. 3B, line 4).
Truncated fragments of the MUC1 promoter (BstXI/XmnI
and XmaI/XmnI) that contained the TATA-box but lacked 5P
upstream sequences exhibited CAT activities at lower levels
than the construct containing the full SacI/XmnI fragment. In
order to determine whether sequences located 5P upstream to
the TATA-box possess TATA-box independent intrinsic pro-
moter activity or whether they only supply enhancing ele-
ments to the TATA-based promoter, we deleted the TATA-
box from the SacI/XmnI fragment. The resulting SacI/Bsu36I
(3724/3298 bp) fragment was tested for promoter activity in
a CAT assay (Fig. 2B, line 5). Surprisingly, the SacI/Bsu36I
‘TATA-less’ fragment revealed a very high CAT activity in
the Cf2Th system (212.8%) and a quite substantial activity in
epithelial cells (80%). Although the SacI/Bsu36I fragment does
not contain a TATA-box, it includes two other promoter
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elements, transcription initiators, Inr, at 3661/3653 and
3634/3627 positions which may initiate formation of RNA
polymerase II transcription complexes in TATA-box-less pro-
moters [26].
The main conclusion of the functional analysis performed
in this study is that both the 5P and 3P regions of the SacI/
XmnI fragment possess independent promoter activities in
transfection assays. On this basis, we hypothesize that the
MUC1 gene exhibits characteristics of a ‘dual’ promoter.
3.4. TSSs of the MUC1 gene in T47D cells
Detection of promoter activities, associated with di¡erent
regions of the MUC1 promoter, raised the possibility that
transcription of the MUC1 gene may occur from di¡erent
TSSs. To test this possibility, we analyzed transcription of
the MUC1 gene in T47D cells using a RPA.
Four TSSs associated with transcription of the MUC1 gene
were detected in T47D cells grown under regular growth con-
ditions (Fig. 4, IIA). The major TSS, closest to the ATG start
codon, is located 24 nucleotides downstream from the TATA-
box (30^35 nucleotides upstream to the XmnI restriction site
as indicated in Fig. 4, I) and corresponds to a classical TATA-
box-controlled TSS [27,28]. The second TSS virtually overlaps
the TATA-box. The third and the fourth TSSs are located 20^
25 and 40^45 nucleotides upstream to the TATA-box, respec-
tively, and, therefore, are probably controlled by elements
other than TATA-box.
Thus, transcription of the MUC1 gene in T47D cells is
associated with multiple transcription start points. It should
be pointed out that transcription from the fourth TSS appears
to be rather weak and could be observed only after a long
exposure (7 days). However, no additional TSSs were detected
even after longer (2 weeks) exposures.
3.5. TGFL1-induced TSSs
As we showed above, in T47D cells cultivated under nor-
mal growth conditions, the MUC1 speci¢c TSSs were posi-
tioned between +1 and 370 nucleotides at the 3P end of
the promoter (Fig. 4, IIA). No other TSSs located at the
5P end of the MUC1 promoter were observed in cells cultured
under these conditions. On the other hand, the CAT trans-
fection experiments demonstrated promoter activity associ-
ated also with the 5P end 3724/3298 fragment. This fragment
contains many transcription cis-elements (Fig. 2), including
two initiators (3661/3653, 3634/3627) which might drive
independent transcription activity of this fragment. Based
on these data, we presumed that additional TSSs might be
activated following treatment of the cells with various ac-
tivators.
The T47D cells possess TGFL receptors [31] and the SacI/
XmnI fragment contains two TGFL-activated elements at
3625/3609 and 3224/3208 positions (Fig. 2). Therefore,
we chose TGFL1 as a potential activator of the MUC1 gene
in T47D cells. Indeed, TGFL1 activated two additional TSSs
Fig. 3. CAT assay of the MUC1 promoter activity. A: A scheme of the MUC1 gene. B: CAT activities in T47D, HBL-100 and Cf2Th cells
transfected with pPr/CAT/enh plasmid containing the Sac1/Xmn1 fragment of the MUC1 gene promoter (line 1) or its deletion mutant forms
(lines 2^5). For negative control, pCAT/enh plasmid without promoter sequence was used (line 6). For positive control, pCAT/enh plasmid
containing LTR of LPD retrovirus was used (line 7).
Fig. 2. The map of the potential transcription cis-elements present in the SacI/XmnI fragment of the MUC1 promoter. The cis-element abbrevia-
tions are as described [12,13,22^27,33^35]. Roman numerals correspond to the clusters located along the SacI/XmnI fragment in 3P to 5P direction.
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(Fig. 4, IIB) located between 3500 and 3550 nucleotides and
at approximately the 3130 nucleotide position.
These data con¢rmed our results obtained in transfection
assays that both the 5P and 3P regions of the SacI/XmnI frag-
ment of the MUC1 promoter possess promoter activities and
may drive transcription of the MUC1 gene from di¡erent
TSSs.
4. Discussion
Interaction of transcription factors with speci¢c cis-ele-
ments is a cornerstone of transcriptional regulation. More
complex patterns of gene transcription demand increasingly
elaborate promoter structure and functions. The MUC1
gene directs synthesis of several protein isoforms with a di-
verse spectrum of functions [4^9]. Although expression of the
MUC1 gene is observed mostly in epithelial cells, its tran-
scription, albeit at low levels, was detected also in other types
of cells : normal and neoplastic plasma cells [32,33], follicular
dendritic cells [32], Hodgkin and non-Hodgkin lymphomas
cells [34,35], myo¢broblasts and perineurial cells [32]. Re-
cently, it has been shown that MUC1 gene expression can
also be induced in T-cells [11]. The MUC1 gene expression
is not only cell and tissue speci¢c, but also developmentally
regulated [36]. Alltogether, these data allow one to suppose
that the MUC1 promoter should have a high level of com-
plexity. As the MUC1 promoter can drive transcription in the
several types of cells mentioned above, a priori, it should
contain di¡erent cis-elements that are speci¢c for transcription
in, at least, these cells.
The results obtained by our analysis of the potential cis-
elements in the MUC1 promoter are in agreement with this
assumption. They revealed extensive structural intricacy of the
promoter. The MUC1 promoter contains the transcriptional
cis-elements speci¢c for mammary epithelial cells, hemato-
poetic cells, B- and T-lymphocytes, hepatocytes and muscle
cells. This means that theoretically, the MUC1 gene has the
potential to be transcribed in these cells, which correlates well
with recent experimental data demonstrating MUC1 gene ex-
pression in cells mentioned above [11,32^35]. Thus, the
MUC1 promoter seems to be unique among eukaryotic pro-
moters in its assortment of diverse regulatory elements. It
includes elements characteristic of di¡erentiation speci¢c, fac-
ultative and housekeeping genes, as well as viral genes. Multi-
ple, overlapping cis-elements characterized by diverse tran-
scriptional speci¢city de¢ne numerous clusters along the
MUC1 promoter DNA. The cluster structure found in the
MUC1 promoter suggests ‘modules’ of regulatory units whose
activities may be regulated by spatially and temporally coor-
dinated programs [37].
Structural complexity of the MUC1 promoter correlates
with its functional activities revealed by transfection analyses
and by RPAs. Our study showed that the 0.8 kb SacI/XmnI
fragment, although it comprises only one fourth of the full
MUC1 promoter length, contains a set of the cis-elements that
are competent and su⁄cient for driving expression of the
MUC1 protein, at least its tandem repeat containing iso-
form(s), in mouse epithelial cells. It is important that this
small fragment of the MUC1 promoter controls not only
epithelial cell speci¢c transcription but can also regulate
gene transcription in lymphoid cells. We showed that the re-
gion corresponding to a 25 nucleotide sequence located 5P
upstream to the BstX1 site and composed of T-cell speci¢c
cis-elements (Pu-box, Ikaros 1, Ikaros 2 and K-IRE) substan-
Fig. 4. Detection of the TSSs associated with the MUC1 gene transcription in T47D cells. I: A scheme of the TSS localization in the Sac1/
Xmn1 fragment of the MUC1 gene promoter. The ¢lled triangles indicate the positions of the TSSs associated with the MUC1 gene transcrip-
tion in non-treated T47D cells, the opened triangles correspond to TSSs in T47D cells treated with TGFL1. II: Detection of the MUC1 gene
speci¢c TSSs by electrophoresis of the RNase-protected fragments in a 6% polyacrylamide gel with 8 M urea. A: RNase-protected fragments
of the MUC1 speci¢c transcripts from T47D cells. Lanes 1^4 contain 10, 15, 30 and 50 Wg of total RNA, respectively. M: markers. B: RNase-
protected fragments of the MUC1 speci¢c transcripts from T47D cells treated with TGFL1 (5 ng/ml, 48 h). Lanes 1 and 2: empty, lane 3 con-
tains 50 Wg RNA. M: markers. C: Detection of the size and speci¢city of the MUC1 promoter (SacI/XmnI speci¢c) RNA probe. Lanes 1, 3
and 5 are empty. Lane 2: RNA probe hybridized with 50 Wg yeast tRNA and non-treated with RNase. Lane 4: RNA probe hybridized with
50 Wg yeast tRNA and treated with RNase. M: markers.
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tially and speci¢cally increased transcription of the CAT test
gene in embryonal thymus Cf2Th cells. The presence in the
MUC1 promoter of cis-elements that may upregulate gene
transcription in lymphoid cells correlates well with the obser-
vation that the MUC1 gene can be activated in T-cells [11].
Utilizing deleted forms of the SacI/XmnI promoter frag-
ment in CAT transfection assays, we showed that 5P and 3P
regions of the MUC1 promoter possess independent promoter
activities which could be observed when two regions were
separated from each other. We hypothesize that TATA-box
and GC-boxes located at 330/325 and 390/3137, respec-
tively, could govern formation of the initial transcription com-
plex (ITC) in the 3P end-regulated transcription while two
initiator elements, TFII-1-ML-Inr2 (3661/3653) and TdT
Inr (3634/3627), might control ITC formation in the 5P
end-regulated transcription, as it was observed in some other
genes [26].
This hypothesis was con¢rmed by RPAs which showed that
transcription of the MUC1 gene in T47D cells was associated
with multiple TSSs located both at the 3P and 5P ends of the
SacI/XmnI region of the MUC1 promoter. In non-treated
cells, the TSSs were generated by the 3P end of the promoter
and were located in the vicinity of the TATA- and GC-boxes.
Treatment with TGFL1 induced additional TSSs located at
the 5P end of the SacI/XmnI fragment.
Previous studies [25] showed that GC-boxes located at 399/
390 bp are involved in MUC1 gene transcription regulation
in epithelial cells. We suggest that some of the GC-boxes
positioned at the 3P end of the MUC1 promoter may drive
transcription independently of the TATA-box. This may ex-
plain our ¢nding of TSSs located upstream to the TATA-box
but downstream to the GC-boxes. In this scenario, multiple
promoter activities are associated with TATA-box, GC-boxes
and Inr elements bestowing MUC1 promoter with character-
istics of a mixed polypotent promoter. Further analysis using
site speci¢c mutagenesis is currently undertaken to clarify the
roles of the discussed elements in transcriptional regulation of
the MUC1 gene.
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